

Cover Story
Free
This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, the Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
In Brief


Drugs & Targets
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Trump imposes up to 100% tariff on some brand name pharmaceutical companies
- Michael Bishop, Nobel-winning cancer researcher, dies at 90
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case











